Dark

KALA
KALA BIO, Inc. Common Stock
stock NASDAQ

At Close

Sep 16, 2026 3:59:30 PM EDT

0.5216USD+2.738%(+0.0139)166,571

0.4400Bid 0.6400Ask 0.2000Spread

Pre-market

Sep 16, 2026 9:27:30 AM EDT

0.5086USD+0.177%(+0.0009)7,213

After-hours

Sep 16, 2026 4:21:30 PM EDT

0.5216USD0.000%(0.0000)1,000

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

10.09M

CEO

Mark Iwicki

Headquarters

Watertown, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

Last Split

May 11, 20261for50reverse

OMER XLV

KALA Stats

Avg. Vol. 10 Day

1,184,888

Avg. Vol. 30 Day

523,241

Employees

Market Cap

10,087,632

Shares Out.

19,339,786

On/Off Exchange

39%/61%

6 Month Beta

2.39

1 Year Beta

2.07

2 Year Beta

1.46

3 Year Beta

1.21

52 Week Low

0.49

52 Week High

1,030.00

SMA50

0.79

SMA200

12.67

1 Week

-6.31%

1 Month

-42.69%

3 Month

-83.39%

6 Month

-96.08%

1 Year

-99.94%

2 Year

-99.82%

5 Year

-99.99%

Profile

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.

KALA Stock Summary

KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $0.5216, and today's volume is 166,571. KALA is up 2.738% today. The 30 day average volume is 523,241. KALA market cap is 10.09M with 19,339,786 shares outstanding.